Hematology studies often involve complex treatment regimens, specialized clinical assessments, long-term safety monitoring, and highly individualized participant journeys. From leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes to sickle cell disease, hemophilia, thrombosis, and other rare blood disorders, sponsors need flexible technology that simplifies study execution while supporting high-quality clinical and patient-reported data collection.

THREAD combines configurable clinical research technology with scientific consulting expertise to help sponsors design and execute hematology studies more efficiently. Our Human-Centered Design approach reduces participant burden, improves long-term engagement, and enables the collection of meaningful clinical, laboratory, and patient-reported outcomes across traditional, hybrid, and decentralized clinical trials.